Detalhe da pesquisa
1.
The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis.
J Transl Med;
21(1): 552, 2023 08 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37592303
2.
High NANOG expression correlates with worse patients' survival in esophageal adenocarcinoma.
BMC Cancer;
23(1): 669, 2023 Jul 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37461005
3.
Fetal gut cell-like differentiation in esophageal adenocarcinoma defines a rare tumor subtype with therapeutically relevant claudin-6 positivity and SWI/SNF gene alteration.
Sci Rep;
14(1): 13474, 2024 06 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38866822
4.
Upregulation of the histone γ-H2AX correlates with worse patient survival and basal-like subtype in pancreatic ductal adenocarcinoma.
J Cancer Res Clin Oncol;
150(3): 137, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38502354
5.
Co-expression patterns of cancer associated fibroblast markers reveal distinct subgroups related to patient survival in oropharyngeal squamous cell carcinoma.
Front Cell Dev Biol;
12: 1337361, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38328551
6.
An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL.
Cell Rep Med;
5(2): 101421, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38340727
7.
Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease.
J Cancer Res Clin Oncol;
149(10): 6917-6929, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36826594
8.
Copy-number-gain of telomerase reverse transcriptase (hTERT) is associated with an unfavorable prognosis in esophageal adenocarcinoma.
Sci Rep;
13(1): 17699, 2023 10 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37848472
9.
RNA Sequencing Reveals Alterations and Similarities in Cell Metabolism, Hypoxia and Immune Evasion in Primary Cell Cultures of Clear Cell Renal Cell Carcinoma.
Front Oncol;
12: 883195, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35646693
10.
Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levels.
Int J Oncol;
60(2)2022 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35059737
11.
Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior.
Sci Rep;
10(1): 18857, 2020 11 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33139776
12.
Targeting glycolysis with 2-deoxy-D-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors.
J Cancer Res Clin Oncol;
146(9): 2255-2265, 2020 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32533404